GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PLRX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Pliant Therapeutics Inc. stock price fell more than -5.21% Thursday closing at $12.19
(Updated on Apr 18, 2024)

Sell candidate since Apr 12, 2024 Loss -13.85% PDF

The Pliant Therapeutics Inc. stock price fell by -5.21% on the last day (Thursday, 18th Apr 2024) from $12.86 to $12.19. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 7.16% from a day low at $12.01 to a day high of $12.87. The price has fallen in 6 of the last 10 days and is down by -16.22% for this period. Volume has increased on the last day by 76 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 343 thousand shares were bought and sold for approximately $4.18 million.

The stock has broken the wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($12.23) are considered to be a "second chance" to get out. According to the fan-theory $9.57 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PLRX Signals & Forecast

There are few to no technical positive signals at the moment. The Pliant Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $13.52 and $14.75. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, February 27, 2024, and so far it has fallen -29.17%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Pliant Therapeutics Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.86 between high and low, or 7.16%. For the last week, the stock has had daily average volatility of 4.62%.

Pliant Therapeutics Inc. is oversold on RSI14 (19). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PLRX) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Pliant Therapeutics Inc. to open at $12.36, and during the day (based on 14 day Average True Range), to move between $11.50 and $12.88, which gives a possible trading interval of +/-$0.687 (+/-5.64%) up or down from last closing price. If Pliant Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 11.27% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $14.65, some $2.46 (20.18%) from the current price of $12.19, our system finds the risk reward not very attractive.

Is Pliant Therapeutics Inc. stock A Buy?

Pliant Therapeutics Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -7.974 Strong Sell Candidate Downgraded

Predicted Opening Price for Pliant Therapeutics Inc. of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$12.36 ( 1.37%) $12.19

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PLRX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 13.22 8.42 %
R2 12.89 5.73 %
R1 12.69 4.06 %
Current price: 12.19
Support S1 12.03 -1.33 %
S2 11.83 -2.99 %
S3 11.50 -5.69 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 14.90 22.23 %
R2 14.70 20.59 %
R1 14.65 20.18 %
Current price 12.19
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Pliant Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Pliant Therapeutics Inc. is PLRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Pliant Therapeutics Inc. Stock?
Pliant Therapeutics Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy Pliant Therapeutics Inc. Stock?
Pliant Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Pliant Therapeutics Inc. Stock.

What's the current price of Pliant Therapeutics Inc. Stock?
As of the end of day on the 2024-04-18, the price of an Pliant Therapeutics Inc. (PLRX) share was $12.19.

What is the 52-week high and low for Pliant Therapeutics Inc. Stock?
The 52-week high for Pliant Therapeutics Inc. Stock is $30.84 and the 52-week low is $12.01.

What is the market capitalization of Pliant Therapeutics Inc. Stock?
As of the 2024-04-18, the market capitalization of Pliant Therapeutics Inc. is 734.316M.

When is the next earnings date for Pliant Therapeutics Inc.?
The upcoming earnings date for Pliant Therapeutics Inc. is May 14, 2024.
Click to get the best stock tips daily for free!

About Pliant Therapeutics Inc.

Pliant Therapeutics. Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a trials. The company also develops PLN-1474, a small-molecule selective inhibitor of avß1, which complet... PLRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT